Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure

Sponsor
University of Chicago (Other)
Overall Status
Completed
CT.gov ID
NCT01680783
Collaborator
(none)
83
1
2
44
1.9

Study Details

Study Description

Brief Summary

The objective of our study is to evaluate the efficacy of helmet ventilation as compared with Face mask in patients with respiratory failure.

Condition or Disease Intervention/Treatment Phase
  • Device: Non invasive ventilation using a helmet hyperbaric device
  • Other: Noninvasive ventilation via facemask
N/A

Detailed Description

Respiratory failure is often treated with endotracheal intubation and mechanical ventilation. Although, the institution of mechanical ventilation is considered life saving, the associated complications of tracheal stenosis, ventilator associated pneumonia, barotrauma , and neuromuscular weakness are not without considerable morbidity and mortality.

Non-invasive ventilation has demonstrated significant benefit in patients with hypercapnic respiratory failure from COPD, acute cardiogenic pulmonary edema, and hypoxemic respiratory failure in immunocompromised patients.

Despite the advantages of non-invasive ventilation via facemask, some patients fail because of mask intolerance and severity of disease. Further limitation to facemask non-invasive ventilation is that the seal integrity is lost when higher pressures are required. Unfortunately, certain types of respiratory failure such as that due to hypoxemia or shock may require such higher pressures.

In an attempt to improve patient tolerability and deliver higher pressures, a transparent helmet has been proposed as a novel interface for non-invasive ventilation. It encloses the entire head and neck of the patient. The design of the helmet confers some important advantages: 1) the transparency allows the patient to interact with the environment; 2) the lack of contact to the face lowers the risk of skin necrosis; 3) the helmet avoids problems of leaking with higher airway pressures that are seen with the face mask; 4) it can be applied to any patient regardless of facial contour.

Study Design

Study Type:
Interventional
Actual Enrollment :
83 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Mechanical Ventilation in Patients With \Respiratory Failure: A Comparison of Face Mask and Non Invasive Ventilation Via a Helmet Device
Study Start Date :
Sep 1, 2012
Actual Primary Completion Date :
May 1, 2016
Actual Study Completion Date :
May 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Other: Usual Care

Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask.

Other: Noninvasive ventilation via facemask
Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask
Other Names:
  • mechanical ventilation
  • Experimental: Non invasive ventilation via helmet

    Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure

    Device: Non invasive ventilation using a helmet hyperbaric device
    Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay.
    Other Names:
  • Sea-Long medical treatment hood
  • Outcome Measures

    Primary Outcome Measures

    1. Need for Endotracheal Intubation [6 weeks]

      Number of patients requiring endotracheal intubation after application of helmet device

    Secondary Outcome Measures

    1. Hospital Length of Stay [Duration of hospital stay]

      Days spent in hospital at time of enrollment

    2. Number of Participants Functional Status After Discharge [Measured at 1, 6, and 12 months after hospital discharge (to span time frame of up to 80 weeks depending on length of hospitalization)]

      Telephone survey of patients 1, 6, and 12 months after discharge to assess need for re-hospitalization, admission to nursing home, and functional status (ability to complete ADLs and IADLs independently)

    3. Ventilator-free Days [number of days in the hospital]

      Duration of mechanical ventilation via endotracheal tube

    4. Hospital Mortality [90 days]

      Death from any cause during hospitalization at time of enrollment

    5. Intensive Care Unit Length of Stay [4 weeks]

      Number of days admitted to a medical intensive care unit

    Other Outcome Measures

    1. ICU Complications [6 weeks]

      ICU complications will include rates of Ventilator associated pneumonia, Barotrauma, Gastrointestinal hemorrhage, Pulmonary embolism, Sacral Decubitus ulcer, Delirium, ICU acquired weakness

    2. Readmission to the Intensive Care Unit [6 weeks]

      Measure the need for readmission to the intensive care unit during initial hospitalization at time of enrollment

    3. Discharge Location [6 weeks]

      Measure the location (ie home, rehabilitation center, nursing home) that patients are discharged to

    4. Improvement of Oxygenation [2 weeks]

      Improvement of oxygenation-defined as PaO2/FiO2 ≥ 200 or increase from baseline by 100

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients aged ≥18 years of age who require noninvasive ventilation via facemask for

    8hours

    • Intact airway protective gag reflex

    • Able to follow instructions

    Exclusion Criteria:
    • Cardiopulmonary arrest

    • Glasgow coma scale <8

    • Absence of airway protective gag reflex

    • Elevated intracranial pressure

    • Tracheostomy

    • Upper airway obstruction

    • Pregnancy.

    • Patients who refuse to undergo endotracheal intubation, whatever the initial therapeutic approach

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Chicago Medical Center Chicago Illinois United States 60637

    Sponsors and Collaborators

    • University of Chicago

    Investigators

    • Principal Investigator: John P Kress, MD, University of Chicago

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Chicago
    ClinicalTrials.gov Identifier:
    NCT01680783
    Other Study ID Numbers:
    • 12-1391
    First Posted:
    Sep 7, 2012
    Last Update Posted:
    Jul 14, 2020
    Last Verified:
    Jul 1, 2020

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Usual Care Non Invasive Ventilation Via Helmet
    Arm/Group Description Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay.
    Period Title: Overall Study
    STARTED 39 44
    COMPLETED 39 44
    NOT COMPLETED 0 0

    Baseline Characteristics

    Arm/Group Title Usual Care Non Invasive Ventilation Via Helmet Total
    Arm/Group Description Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay. Total of all reporting groups
    Overall Participants 39 44 83
    Age (years) [Median (Inter-Quartile Range) ]
    Median (Inter-Quartile Range) [years]
    60.9
    58
    59
    Sex: Female, Male (Count of Participants)
    Female
    18
    46.2%
    20
    45.5%
    38
    45.8%
    Male
    21
    53.8%
    24
    54.5%
    45
    54.2%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    0
    0%
    0
    0%
    0
    0%
    Asian
    1
    2.6%
    2
    4.5%
    3
    3.6%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    0
    0%
    0
    0%
    Black or African American
    22
    56.4%
    28
    63.6%
    50
    60.2%
    White
    16
    41%
    14
    31.8%
    30
    36.1%
    More than one race
    0
    0%
    0
    0%
    0
    0%
    Unknown or Not Reported
    0
    0%
    0
    0%
    0
    0%

    Outcome Measures

    1. Primary Outcome
    Title Need for Endotracheal Intubation
    Description Number of patients requiring endotracheal intubation after application of helmet device
    Time Frame 6 weeks

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Usual Care Non Invasive Ventilation Via Helmet
    Arm/Group Description Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay.
    Measure Participants 39 44
    Count of Participants [Participants]
    24
    61.5%
    8
    18.2%
    2. Secondary Outcome
    Title Hospital Length of Stay
    Description Days spent in hospital at time of enrollment
    Time Frame Duration of hospital stay

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Usual Care Non Invasive Ventilation Via Helmet
    Arm/Group Description Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay.
    Measure Participants 39 44
    Median (Inter-Quartile Range) [days]
    15.2
    10.1
    3. Secondary Outcome
    Title Number of Participants Functional Status After Discharge
    Description Telephone survey of patients 1, 6, and 12 months after discharge to assess need for re-hospitalization, admission to nursing home, and functional status (ability to complete ADLs and IADLs independently)
    Time Frame Measured at 1, 6, and 12 months after hospital discharge (to span time frame of up to 80 weeks depending on length of hospitalization)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Usual Care Non Invasive Ventilation Via Helmet
    Arm/Group Description Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay.
    Measure Participants 39 44
    Count of Participants [Participants]
    6
    15.4%
    22
    50%
    4. Secondary Outcome
    Title Ventilator-free Days
    Description Duration of mechanical ventilation via endotracheal tube
    Time Frame number of days in the hospital

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Usual Care Non Invasive Ventilation Via Helmet
    Arm/Group Description Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay.
    Measure Participants 39 44
    Median (Inter-Quartile Range) [days]
    12.5
    28
    5. Secondary Outcome
    Title Hospital Mortality
    Description Death from any cause during hospitalization at time of enrollment
    Time Frame 90 days

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Usual Care Non Invasive Ventilation Via Helmet
    Arm/Group Description Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay.
    Measure Participants 39 44
    Count of Participants [Participants]
    19
    48.7%
    12
    27.3%
    6. Secondary Outcome
    Title Intensive Care Unit Length of Stay
    Description Number of days admitted to a medical intensive care unit
    Time Frame 4 weeks

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Usual Care Non Invasive Ventilation Via Helmet
    Arm/Group Description Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay.
    Measure Participants 39 44
    Median (Inter-Quartile Range) [days]
    7.8
    4.7
    7. Other Pre-specified Outcome
    Title ICU Complications
    Description ICU complications will include rates of Ventilator associated pneumonia, Barotrauma, Gastrointestinal hemorrhage, Pulmonary embolism, Sacral Decubitus ulcer, Delirium, ICU acquired weakness
    Time Frame 6 weeks

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title
    Arm/Group Description
    8. Other Pre-specified Outcome
    Title Readmission to the Intensive Care Unit
    Description Measure the need for readmission to the intensive care unit during initial hospitalization at time of enrollment
    Time Frame 6 weeks

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title
    Arm/Group Description
    9. Other Pre-specified Outcome
    Title Discharge Location
    Description Measure the location (ie home, rehabilitation center, nursing home) that patients are discharged to
    Time Frame 6 weeks

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title
    Arm/Group Description
    10. Other Pre-specified Outcome
    Title Improvement of Oxygenation
    Description Improvement of oxygenation-defined as PaO2/FiO2 ≥ 200 or increase from baseline by 100
    Time Frame 2 weeks

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title
    Arm/Group Description

    Adverse Events

    Time Frame 6 months
    Adverse Event Reporting Description
    Arm/Group Title Usual Care Non Invasive Ventilation Via Helmet
    Arm/Group Description Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay.
    All Cause Mortality
    Usual Care Non Invasive Ventilation Via Helmet
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 22/39 (56.4%) 12/44 (27.3%)
    Serious Adverse Events
    Usual Care Non Invasive Ventilation Via Helmet
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/39 (0%) 0/44 (0%)
    Other (Not Including Serious) Adverse Events
    Usual Care Non Invasive Ventilation Via Helmet
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/39 (0%) 0/44 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title John P. Kress
    Organization University of Chicago
    Phone 7737026790
    Email jkress@medicine.bsd.uchicago.edu
    Responsible Party:
    University of Chicago
    ClinicalTrials.gov Identifier:
    NCT01680783
    Other Study ID Numbers:
    • 12-1391
    First Posted:
    Sep 7, 2012
    Last Update Posted:
    Jul 14, 2020
    Last Verified:
    Jul 1, 2020